Investments accounted for using the equity method (Tables)

12 Months Ended

Dec. 31, 2025

The following table summarizes the development of the investments in associates during year 2025:


		Centauri
		Therapeutics	Insignificant
in k€		Ltd	investments		Total
Balance at January 1, 2025		1,264	874		2,138
Investment		3,576	—		3,576
Share of profit/(loss) in associate		(634)	(451)		(1,085)
Impairment		—	—		—
Dividends earned, Divestment or Reclassification		—	—		—
Balance at December 31, 2025		4,206	423		4,629

The following table provides an overview of the development of the investments in 2024:


				Centauri			Quantro		Topas
		Autobahn		Therapeutics		EIR	Therapeutics		Therapeutics		Insignificant
in k€		Labs LLC		Ltd.		Biotherapies	GmbH		GmbH		investments		Total
Balance at January 1, 2024		—		2,179		—	892		—		—		3,071
Investment		1,378		—		1,022	—		977		2		3,379
Share of profit/(loss) in associate		(1,378)		(916)		(149)	(892)		(977)		—		(4,312)
Impairment		—		—		—	—		—		—		—
Dividends earned, Divestment or Reclassification		—		—		—	—		—		—		—
Balance at December 31, 2024		—		1,264		873	—		—		2		2,138

Further financial information on the significant investments accounted for using the equity method is presented below:

2025

2024